RenovoRx RNXT
NASDAQ RNXT
$1.32 +0.00 (+0.00%)
As of: Aug 21, 2026 · 2:23 PM EDT

RenovoRx (RNXT) Operating Margin Growth (1y) (2026)

RenovoRx (RNXT) Operating Margin Growth (1y) (2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 138.81 Bn 130.96 Bn 2.84 Bn -143.00
2 Regeneron Pharmaceuticals 86.07 Bn 78.08 Bn 3.93 Bn 78.00
3 Argenx Se 65.47 Bn 60.29 Bn 1.37 Bn 1,135.00
4 Moderna 55.64 Bn 50.50 Bn 52.00 Mn 7,666.00
5 BeOne Medicines 41.99 Bn 36.89 Bn 1.53 Bn 1,238.00
6 Alnylam Pharmaceuticals 31.68 Bn 28.37 Bn 992.69 Mn 2,002.00
7 BioNTech SE 27.69 Bn 9.29 Bn 668.28 Mn -3,558.00
8 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 29,091.00
9 Royalty Pharma 27.36 Bn 26.52 Bn - -1,651.00
10 RenovoRx 62.43 Mn 62.43 Mn 766,000.00 26,617.00

Historic Data

Download Data
DateValue
Jun 30, 2026 26,617.00
Mar 31, 2026 96,252.00